Study: Live H5N1 Virus Vaccines Effective
Posted on: Tuesday, 12 September 2006, 15:01 CDT
U.S. scientists say live, weakened versions of differing strains of avian flu viruses have offered protection when tested in mice and ferrets.
Researchers say their findings are encouraging because they demonstrate the ability to create a vaccine based on one particular strain of the H5N1 flu virus that could potentially protect against different emerging H5N1 flu strains.
If an influenza pandemic were imminent or under way, we would need a vaccine that could stimulate immunity quickly, preferably with a single dose, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "The encouraging findings of this study suggest vaccines based on live, but weakened, versions of the H5N1 avian influenza virus may quickly stimulate protective immunity.
We are further exploring this live, attenuated vaccine strategy as one of several tools that we hope to have available in the event of an influenza pandemic, he added.
Senior investigator Dr. Kanta Subbarao and co-chief investigator Dr. Brian Murphy explain the research in the Sept. 12 issue of PLoS Medicine.
Source: United Press International
Related Articles
- Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
- Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for Its Influenza Vaccine Global Stockpile
- Sinovac Receives China State Food and Drug Administration (SFDA) Approval for Pandemic Influenza H5N1 Vaccine
- Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
- Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
- Sinovac Attended 3rd WHO Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials
- Sinovac Announces Its Clinical Trial Results of a Pandemic Influenza (H5N1) Vaccine Are Published By The Lancet
- H5N1 Vaccine Could Be Basis for Life-Saving Stockpile
- Skystar Bio-Pharmaceutical Developing Avian Influenza (H5N1) Vaccine for Humans and Animals
- Sinovac Biotech Ltd. Begins Pandemic Flu (H5N1) Vaccine Clinical Trials
User Comments (0)

RSS Feeds